LinkedIn Profile

Access Euretos historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:euretos 3334296 Jun 12th, 2022 12:00AM Euretos 1.8K 20.00 Open Biotechnology Jun 12th, 2022 12:51AM Jun 12th, 2022 12:51AM Data-Driven Disease Insight We collaborate with our customers to unravel the complexities of human disease biology, reducing the risk and cost of therapy development. We generate data driven disease insights through a unique combination of AI driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers our customers to draw their own conclusions and take a data driven approach to disease and drug research. Euretos AI Platform The Euretos AI Platform empowers researchers to draw evidence-based conclusions. It is used indepently but also as an integral part of our consulting projects. Leverage information from millions of machine-read publications and hundreds of data sources such as genetic, genomic and proteomic annotations, expression profiles, patents and much more. Generate hypotheses and evaluate evidence using a suite of applications including Search, Analytics, Knowledge Graph and many task-optimised Workflows. Target Discovery / Indication Selection Consulting In our projects we focus on target discovery and indication selection. In these areas, our computational disease models and translational biology consulting have been tried and tested in many collaborations with leading pharma and biotech companies. Our translational consultants will help you interpret the outcomes of our computational disease modeling. In addition, direct access to the Euretos AI Platform enables you to review results within the context of existing evidence from public biomolecular databases, publications and patents. Combine your proprietary data and therapeutic expertise with our disease models, translational consultants and AI platform to gain collaborative, data driven disease insights. Open Target Identification, Biomarker Discovery, Drug Repositioning, Multi Omics Analysis, Life Sciences Data Integration, Computational Biology, Big Data Analytics, Literature Search, Semantic Integration Open Yalelaan 1 Utrecht NL 3584 Euretos
private:euretos 3334296 May 26th, 2022 12:00AM Euretos 1.8K 20.00 Open Biotechnology May 25th, 2022 11:18PM May 26th, 2022 10:02AM Data-Driven Disease Insight We collaborate with our customers to unravel the complexities of human disease biology, reducing the risk and cost of therapy development. We generate data driven disease insights through a unique combination of AI driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers our customers to draw their own conclusions and take a data driven approach to disease and drug research. Euretos AI Platform The Euretos AI Platform empowers researchers to draw evidence-based conclusions. It is used indepently but also as an integral part of our consulting projects. Leverage information from millions of machine-read publications and hundreds of data sources such as genetic, genomic and proteomic annotations, expression profiles, patents and much more. Generate hypotheses and evaluate evidence using a suite of applications including Search, Analytics, Knowledge Graph and many task-optimised Workflows. Target Discovery / Indication Selection Consulting In our projects we focus on target discovery and indication selection. In these areas, our computational disease models and translational biology consulting have been tried and tested in many collaborations with leading pharma and biotech companies. Our translational consultants will help you interpret the outcomes of our computational disease modeling. In addition, direct access to the Euretos AI Platform enables you to review results within the context of existing evidence from public biomolecular databases, publications and patents. Combine your proprietary data and therapeutic expertise with our disease models, translational consultants and AI platform to gain collaborative, data driven disease insights. Open Target Identification, Biomarker Discovery, Drug Repositioning, Multi Omics Analysis, Life Sciences Data Integration, Computational Biology, Big Data Analytics, Literature Search, Semantic Integration Open Yalelaan 1 Utrecht NL 3584 Euretos
private:euretos 3334296 Mar 28th, 2022 12:00AM Euretos 1.7K 19.00 Open Biotechnology Mar 28th, 2022 07:40PM Mar 28th, 2022 07:40PM Data-Driven Disease Insight We collaborate with our customers to unravel the complexities of human disease biology, reducing the risk and cost of therapy development. We generate data driven disease insights through a unique combination of AI driven, computational disease models, translational biology consultancy and direct access to the Euretos AI platform. This empowers our customers to draw their own conclusions and take a data driven approach to disease and drug research. Euretos AI Platform The Euretos AI Platform empowers researchers to draw evidence-based conclusions. It is used indepently but also as an integral part of our consulting projects. Leverage information from millions of machine-read publications and hundreds of data sources such as genetic, genomic and proteomic annotations, expression profiles, patents and much more. Generate hypotheses and evaluate evidence using a suite of applications including Search, Analytics, Knowledge Graph and many task-optimised Workflows. Target Discovery / Indication Selection Consulting In our projects we focus on target discovery and indication selection. In these areas, our computational disease models and translational biology consulting have been tried and tested in many collaborations with leading pharma and biotech companies. Our translational consultants will help you interpret the outcomes of our computational disease modeling. In addition, direct access to the Euretos AI Platform enables you to review results within the context of existing evidence from public biomolecular databases, publications and patents. Combine your proprietary data and therapeutic expertise with our disease models, translational consultants and AI platform to gain collaborative, data driven disease insights. Open Target Identification, Biomarker Discovery, Drug Repositioning, Multi Omics Analysis, Life Sciences Data Integration, Computational Biology, Big Data Analytics, Literature Search, Semantic Integration Open Yalelaan 1 Utrecht NL 3584 Euretos
private:euretos 3334296 Mar 10th, 2022 12:00AM Euretos 1.7K 19.00 Open Biotechnology Mar 10th, 2022 06:48PM